Login

Workiva and Microsoft A connected reporting experience | Dave Mulcahy, CEO, Workiva IncWK:NYQ 00:10:00

Share On Facebook Share On Twitter

Dave Mulcahy is the CEO of this renowned company

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The entrepreneur and the company-building process|Marc Andreessen,Investor, Andreessen Horowitz
00:10:00
Artemis Resources' Strategic Ventures and Exploration Achievements in Western Australia: Highlights from the One-to-One Mining Investment Conference
00:00:00
Johan Wäborg CEO, Iconovo
00:00:00
Anders Rabbe, CEO, Isofol Medical AB (publ)
00:10:00
Examining the Current Credit Landscape with Oak Hill Advisors |Glenn August , CEO, Oak Hill Advisors.
00:10:00
Focuses on early-stage venture investing in mobile, marketplaces, social, infrastructure|Mitch Lasky,Partner,Benchmark
00:10:00
Mondor discusses the expansion of Inseego's 5G product offerings, including mobile hotspots and SaaS solutions, across various markets worldwide.|Dan Mondor Chairman and CEO of Inseego Corp
00:10:00
Identifying and Modeling Airborne Induced Polarization Effects in EM Data
00:10:00
invests in technology companies focused on financial services|Mark Casady,Founder and General Partner,Vestigo Ventures
00:10:00
West Wits Mining: Revitalizing South Africa's Historic Gold Fields
00:10:00
State Street CEO Jay Hooley on Navigating Long-Term Investing and the Strategic Role of ETFs Amid Geopolitical Uncertainty
00:10:00
"Exploring Sustainable Real Estate Strategies with Boston Properties' Sustainability Manager, Ben Myers"|Senior Vice President,Boston Properties Inc

© 2017 - Neuhu+